Press releases 2019

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an order from Helsinki University Hospital worth approximately MSEK 3.3 regarding detectors for Samsung DR systems that will be used for image capturing. Delivery of the equipment is planned to take place at the end of 2019.   For further information, please contact: Rikard Akhtarzand, CEO…

ADDvise Group AB’s (publ) subsidiary AB Germa has received an order from their distributor Bisco worth approximately 2.2 MSEK. The equipment will be used for immobilization of trauma patients and will be used by ambulance personnel in the Middle East. Delivery is planned to take place during Q4 2019 and Q1 2020.   For further…

The Board of Directors of ADDvise Group AB (publ) ("ADDvise" or the “Company"), supported by the authorization that the board of directors received at the Annual General Meeting on April 25, 2019, decided on a directed cash issue of 8,823,529 B-shares at a subscription price of 0.68 SEK per share to an institutional investor (the…

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an allocation decision regarding the delivery of X-ray systems to Päijät-Häme Central Hospital in Lahti to a total value of approximately 3 MSEK. Delivery of the equipment is planned to take place during Q4 2019. The decision is subject to an appeal time expiring July 1st…

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an order from Tampere University Hospital in Finland worth approximately 8.7 MSEK regarding X-ray equipment. The equipment will be used for medical diagnostics. Delivery of the equipment is planned to take place between Q3 2019 – Q1 2020.   For further information, please contact: Rikard Akhtarzand,…

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an order from Tampere University Hospital in Finland worth approximately 2.8 MSEK regarding image capturing equipment that will be used at the hospital’s X-ray department. Delivery of the equipment is planned to take place during Q3/Q4 2019.   For further information, please contact: Rikard Akhtarzand, CEO…

ADDvise Group had a strong order intake during the first quarter of the year. Order intake increased by 33 percent compared with the previous year. The total order intake amounted to SEK 84.4 million. ADDvise Group's total order intake during the first quarter of 2019 amounted to SEK 84.4 million, compared with SEK 63.5 million…

ADDvise Group AB's (publ) subsidiary Sonar Oy has received an allocation decision from Oulaskangas Hospital worth approximately 2.7 MSEK regarding X-ray equipment. Delivery of the equipment is planned to take place during Q3 2019. – We are glad that we through our latest acquisition are strengthening ADDvise’s position on the Finnish market. ADDvise is developing…

ADDvise Group AB (publ) (”ADDvise”) has today finalized the acquisition of Sonar Oy (“Sonar”) that has previously been communicated through a press release published February 28th, 2019. The purchase price amounts to 3.2 MEUR, with two possible earn-outs. Sonar in brief Sonar Oy is a Finnish med-tech company. The product portfolio, among other products, consists…

ADDvise Group AB´s (publ) subsidiary LabRum has received an order from a world leading diagnostic company with it´s headquarters in Geneva, to a value of 2,5 MSEK. The order relates to laboratory furnishings for diagnostic sampling labs. Delivery is planned to Q2 2019. For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se …

ADDvise Group AB´s (publ) subsidiary LabRum has received an order from a biotechnology company focusing on tomorrow´s biopharmaceutical, to a value of 2,7 MSEK. The order relates to laboratory furniture for a newly built laboratory. Delivery is planned to Q2 2019. For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se  Important information: …

ADDvise Group AB’s (publ) subsidiary Hettich Labinstrument AB has received an allocation decision from Västra Götalandsregionen worth approximately 14.4 MSEK regarding blood sampling products. The period of the agreement is two years and starts in May 2019 with the possibility of an extension for a total of two years corresponding to an additional 14.4 MSEK.…

ADDvise Group AB (publ) (”ADDvise”) expect the date of closing of Sonar Oy (“Sonar”) to be April 1st 2019, instead of March 1st 2019 as previously stated in a press release from February 11th 2019. Advisor Mangold Fondkommission AB is the financial adviser and Krogerus is the legal advisor to ADDvise in connection with the…

ADDvise Group AB (publ) ("ADDvise" or the “Company") has completed the rights issue of 43,042,288 units that was announced on December 12, 2018 (the "Rights Issue"). In connection therewith, directed issues are carried out in accordance with the guarantee agreement with the guarantors of the Rights Issue who have chosen to receive guarantee remuneration in…

ADDvise Group AB (publ) (”ADDvise”) has today entered into an agreement with the shareholders of the Finnish company Sonar Oy (“Sonar”) regarding the acquisition of all shares in Sonar. The closing is expected to take place on March 1st, 2019 (the “Acquisition”). The signing of the Letter of Intent regarding the Acquisition was made public…

ADDvise Group AB (publ) (”ADDvise” or the “Company”) has completed the rights issue of 43 042 288 units that was published December 12th2018 (the ”Rights Issue”). The Rights Issue has been subscribed to a total of 106.1 percent, which approximately 92.3 percent was subscribed for with preferential unit rights and approximately 13.8 percent were subscribed without…

Updated financials ADDvise has prepared updated preliminary financials to clarify the impact of ADDvise's latest acquisitions on ADDvise's financials, as well as the ongoing acquisition of the previously mentioned Finnish medtech company the (“Company”) expected effect on the financials. ADDvise preliminary full year 2018 (“Prel FY 18”) financials correspond to a net sales growth of…

ADDvise Group has made a preliminary assessment of the Group revenue and earnings before tax (EBT) for the fourth quarter 2018. Revenue and EBT show strong improvement when compared to the fourth quarter 2017. Revenue in Q4 2018 is estimated to reach 73 MSEK compared to 62 MSEK in Q4 2017, an increase by over…

ADDvise Group AB's (publ) subsidiary Surgical Tables Inc (STI) has entered into an agreement with one of the world's three largest medtech companies with a value of approximately 7,2 MSEK, meaning that STI will produce the newly developed surgical table for spinal fusion procedures. STI has received a first suborder within the framework of the…

The Board of Directors in ADDvise Group AB (publ) ("the Company") publishes an investment memorandum related to the guaranteed rights issue of 24,9 MSEK of units (each consisting of one share of series B and one warrant) by the Company (Rights Issue). The Investment memorandum can now be found on the Company’s webpage www.addvisegroup.se/investor-relations/prospekt-2/ as…

Today ADDvise Group announces that Analyst Group published a research report of ADDvise Group on Analyst Group’s website and can be found at https://analystgroup.se/analysis/addvise-group/ For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The…

ADDvise Group AB’s (publ) subsidiary Labrum has received an order from Cambrex Karlskoga worth 3,2 MSEK regarding laboratory furniture to Cambrex Karlskoga’s newly built laboratory. Delivery is planned to Q2/Q3 2019. For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se  Important information:  This information is by ADDvise Group AB required to disclose…

ADDvise Group’s order intake for Q4 2018 increased by 12 percent compared to Q4 2017. Order intake for Q4 2018 was 74,8 MSEK (66,8 MSEK Q4 2017). Total order intake for 2018 amounted to 261,5 MSEK (243,4 MSEK in 2017) which is an increase by 7,5 percent compared with 2017. – I’m pleased with the…

ADDvise Group AB (publ) announced today that the company has appointed Mangold Fondkommission to provide market making services for the company's shares of series B. The purpose of the market maker is to improve the liquidity of the share and reduce the difference between the buying and selling price. The assignment commences on January 8th…